The EUROPSO Psoriasis Patient Study

THE EUROPSO PSORIASIS PATIENT STUDY: TREATMENT HISTORY AND SATISFACTION REPORTED BY 17,990 MEMBERS OF EUROPEAN PSORIASIS PATIENT ASSOCIATIONS

Salonen S-H on behalf of the EUROPSO Patient Survey Study Group EUROPSO, Helsinki, Finland

INTRODUCTION

Psoriasis can have a profound impact on a person’s quality of life, particularly if it is extensive, affects a visible or sensitive area, or is difficult to treat. To explore the impact of psoriasis on the quality of life of European patients and to learn about patients’ perceptions of current treatments, EUROPSO (European Federation of Psoriasis Patient Organisations) has conducted a large-scale postal survey of the members of nine European patient associations …

europso_survey_en